- Home
- PLCE vs ICCM Comparison
PLCE vs ICCM Comparison
Compare PLCE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- ICCM
- Stock Information
- Founded
- PLCE 1969
- ICCM 2006
- Country
- PLCE United States
- ICCM Israel
- Employees
- PLCE N/A
- ICCM N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- ICCM
- Sector
- PLCE Consumer Discretionary
- ICCM
- Exchange
- PLCE Nasdaq
- ICCM Nasdaq
- Market Cap
- PLCE 76.8M
- ICCM 70.1M
- IPO Year
- PLCE 1997
- ICCM N/A
- Fundamental
- Price
- PLCE $5.71
- ICCM $1.03
- Analyst Decision
- PLCE Hold
- ICCM Strong Buy
- Analyst Count
- PLCE 2
- ICCM 1
- Target Price
- PLCE $9.00
- ICCM $2.50
- AVG Volume (30 Days)
- PLCE 601.6K
- ICCM 199.2K
- Earning Date
- PLCE 06-11-2025
- ICCM 05-27-2025
- Dividend Yield
- PLCE N/A
- ICCM N/A
- EPS Growth
- PLCE N/A
- ICCM N/A
- EPS
- PLCE N/A
- ICCM N/A
- Revenue
- PLCE $1,386,269,000.00
- ICCM $3,291,000.00
- Revenue This Year
- PLCE N/A
- ICCM $97.02
- Revenue Next Year
- PLCE N/A
- ICCM $212.86
- P/E Ratio
- PLCE N/A
- ICCM N/A
- Revenue Growth
- PLCE N/A
- ICCM 1.92
- 52 Week Low
- PLCE $4.77
- ICCM $0.48
- 52 Week High
- PLCE $19.74
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- PLCE 45.68
- ICCM 37.29
- Support Level
- PLCE $4.81
- ICCM $1.00
- Resistance Level
- PLCE $6.00
- ICCM $1.10
- Average True Range (ATR)
- PLCE 0.48
- ICCM 0.08
- MACD
- PLCE 0.17
- ICCM -0.01
- Stochastic Oscillator
- PLCE 57.32
- ICCM 8.82
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.